News & Updates
Filter by Specialty:
Two-dose hep-B vaccine more seroprotective than three-dose regimen in chronic liver disease patients
In a pooled post hoc analysis of three phase III trials, a novel two-dose hepatitis B (hep-B) vaccine regimen trumped the traditional three-dose regimen in inducing seroprotection in patients with chronic liver disease (CLD).
Two-dose hep-B vaccine more seroprotective than three-dose regimen in chronic liver disease patients
02 Dec 2021
Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.
Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
02 Dec 2021
Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor
The glucagon-like peptide-1 receptor agonist (GLP-1 RA) efpeglenatide affords cardiovascular and renal protection that is not explained by concurrent use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor in patients with type 2 diabetes (T2D), according to an exploratory analysis of AMPLITUDE-O.
